EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple Sclerosis International Federation (MSIF) to raise awareness of this challenging disease that affects more than 2.3 million people worldwide. In support of this year’s World MS Day theme, “My Invisible MS” (#MyInvisibleMS), EMD Serono is making MS visible through tailored initiatives and contributions aimed at shining a light on the impact of MS – both for…
Read MoreEMD Serono Makes Multiple Sclerosis Visible This World MS Day and Beyond
